Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of HCK mRNA | affects expression | 21346803
|
C108123 |
4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine |
4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [deoxynivalenol results in increased phosphorylation of and results in increased activity of HCK protein] | decreases reaction|increases activity|increases phosphorylation | 15772366
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of HCK mRNA | affects expression | 17562736
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of HCK mRNA | affects expression | 16483693
|
D002084 |
Butylated Hydroxytoluene |
Butylated Hydroxytoluene affects the expression of HCK mRNA | affects expression | 18539377
|
D019256 |
Cadmium Chloride |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of HCK mRNA | affects cotreatment|decreases expression | 12634122
|
C023600 |
chromium oxide |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of HCK mRNA | affects cotreatment|decreases expression | 12634122
|
C017133 |
chromous chloride |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of HCK mRNA | affects cotreatment|decreases expression | 12634122
|
C014347 |
decitabine |
decitabine affects the methylation of HCK promoter | affects methylation | 17344919
|
C014347 |
decitabine |
[decitabine affects the methylation of HCK promoter] which affects the expression of HCK mRNA | affects expression|affects methylation | 17344919
|
C014347 |
decitabine |
decitabine results in increased expression of HCK protein | increases expression | 17344919
|
C007262 |
deoxynivalenol |
deoxynivalenol results in increased phosphorylation of HCK protein | increases phosphorylation | 20181660
|
C007262 |
deoxynivalenol |
4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [deoxynivalenol results in increased phosphorylation of and results in increased activity of HCK protein] | decreases reaction|increases activity|increases phosphorylation | 15772366
|
C007262 |
deoxynivalenol |
deoxynivalenol results in increased phosphorylation of and results in increased activity of HCK protein | increases activity|increases phosphorylation | 15772366
|
C007262 |
deoxynivalenol |
HCK protein affects the reaction [deoxynivalenol results in increased activity of CASP3 protein] | affects reaction|increases activity | 15772366
|
C007262 |
deoxynivalenol |
HCK protein affects the reaction [deoxynivalenol results in increased expression of TNF protein] | affects reaction|increases expression | 15772366
|
D004041 |
Dietary Fats |
Dietary Fats results in decreased expression of HCK mRNA | decreases expression | 18042831
|
C008261 |
lead acetate |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of HCK mRNA | affects cotreatment|decreases expression | 12634122
|
D026423 |
S-Nitroso-N-Acetylpenicillamine |
S-Nitroso-N-Acetylpenicillamine results in decreased expression of HCK mRNA | decreases expression | 12102619
|
D010126 |
Ozone |
Ozone results in decreased expression of HCK mRNA | decreases expression | 16330353
|
C041786 |
palm oil |
palm oil results in decreased expression of HCK mRNA | decreases expression | 18042831
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of HCK mRNA | decreases expression | 17426115
|
C017947 |
sodium arsenite |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of HCK mRNA | affects cotreatment|decreases expression | 12634122
|
C004648 |
testosterone enanthate |
testosterone enanthate affects the expression of HCK mRNA | affects expression | 17440010
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of HCK mRNA | increases expression | 16054129
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of HCK mRNA | decreases expression | 16604517
|
C030665 |
triphenyltin |
triphenyltin results in increased expression of HCK protein | increases expression | 12788061
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
3.86 | 7525203 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.47 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.03 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.40 | 16434500 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.62 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.82 | 17306315 16712894 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.54 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
2.42 | 15513908 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.76 | 10982225 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
3.80 | 15238619 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.02 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
4.60 | 15570426 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
4.60 | 16292516 |
MESH:D001249 |
Asthma |
|
Ozone |
4.86 | 17854713 16373670 |
MESH:D001249 |
Asthma |
|
Tretinoin |
4.86 | 16456186 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.43 | 18445737 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.32 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.70 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
8.70 | 16197459 16206674 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
1.96 | 19208741 18320071 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
1.96 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
1.96 | 16443354 16873071 16166294 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.60 | 14754758 15516495 17626835 18417511 19059883 18315731 16777450 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.50 | 16813970 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.65 | 16183385 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.08 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
4.47 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
4.47 | 17306315 16507464 15276417 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
4.47 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
7.43 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
7.43 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
7.43 | 16051514 16096774 |
MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
12.08 | 14694615 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
12.08 | 10977129 |
MESH:D002386 |
Cataract |
|
Tretinoin |
12.08 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
2.93 | 20056578 19524636 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.50 | 16129372 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.76 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.08 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.63 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.62 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.32 | 17616700 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.10 | 18981723 |
MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
4.08 | 15095906 |
MESH:D019465 |
Craniofacial Abnormalities |
|
lead acetate |
3.12 | 19769572 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
3.12 | 9211117 16925845 9224671 17551590 9142499 10589399 8800419 14991402 9125849 9664655 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.38 | 18249437 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
3.88 | 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
3.88 | 18071297 17522070 12705907 16177239 10915739 19085960 11287661 15968718 11743745 11834606 12392966 11421492 16485898 17906064 14550746 16109766 12540782 19739265 14986274 11461765 10774834 16781746 19420014 19416960 12153990 12958197 16393943 16227642 2444490 14725611 15619225 16081117 19164858 11529661 10663392 18713872 19923254 17562736 12594235 11739529 19370779 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.02 | 19426721 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.39 | 18367378 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.40 | 12083418 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
4.39 | 18230668 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.03 | 19294695 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.05 | 16569247 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.51 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
7.43 | 17967931 19004024 19551842 18296743 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
7.43 | 19236843 20131406 |
MESH:D005317 |
Fetal Growth Retardation |
|
lead acetate |
5.30 | 19769572 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
8.54 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
8.54 | 17994277 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.59 | 16983495 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.59 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
2.95 | 17312396 |
MESH:D005922 |
Glomerulonephritis, IGA |
|
deoxynivalenol |
4.94 | 15173396 16524712 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
7.63 | 19215824 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
7.63 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.08 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
2.85 | 9664655 14991402 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.48 | 20558911 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
2.91 | 19176532 16221962 19772884 18467677 |
MESH:D019247 |
HIV Wasting Syndrome |
|
testosterone enanthate |
5.67 | 17440010 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.08 | 12676792 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
7.39 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
7.39 | 16870215 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.51 | 21332399 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.48 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
9.58 | 20558911 |
MESH:D006943 |
Hyperglycemia |
|
triphenyltin |
9.58 | 10522495 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.53 | 21332399 |
MESH:D006967 |
Hypersensitivity |
|
Butylated Hydroxytoluene |
4.43 | 17604070 |
MESH:D015228 |
Hypertriglyceridemia |
|
triphenyltin |
5.87 | 10522495 |
MESH:D007246 |
Infertility |
|
triphenyltin |
5.94 | 15205045 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
6.71 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
6.71 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
2.39 | 20412841 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
7.05 | 18457598 11836018 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.05 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.68 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
3.82 | 17551590 15992940 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
9.86 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium Chloride |
9.86 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
9.86 | 20008137 |
MESH:D007938 |
Leukemia |
|
decitabine |
6.28 | 18980019 19235587 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
6.28 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
9.29 | 18454857 19117987 17236224 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
9.29 | 19285840 16482212 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
3.92 | 17679729 18704418 18460780 19387464 19010910 18206229 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
3.92 | 17596541 16294345 19850784 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.38 | 18055864 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.09 | 17339181 15748426 19035177 16140955 19642359 17506722 17712046 16935935 16891316 16766008 9834237 17217047 17107899 19029980 17361223 19225113 19075265 17368321 16788101 16331271 17649720 12679006 17294898 17301526 16823087 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.24 | 9224671 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
2.83 | 18296743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.32 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
2.32 | 16248980 18397230 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.61 | 19014921 12587719 12969438 16611625 19784758 16610002 19460945 11587558 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.16 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
Butylated Hydroxytoluene |
7.38 | 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
7.38 | 15890375 16377806 20007298 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
7.38 | 15276417 16712894 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
7.32 | 8266340 19066396 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
7.32 | 19095001 |
MESH:D055370 |
Lung Injury |
|
Ozone |
3.76 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Butylated Hydroxytoluene |
3.60 | 19925653 15390079 18597497 11246140 11696405 19359593 16337739 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
3.60 | 8597069 7614698 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
3.60 | 17306315 15276417 16712894 17077188 19931552 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.35 | 19470736 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Butylated Hydroxytoluene |
3.69 | 1500032 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.75 | 17453147 |
MESH:D008545 |
Melanoma |
|
decitabine |
5.05 | 16505122 17785578 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
5.05 | 16487513 19082730 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
5.05 | 16752155 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.48 | 19513568 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.34 | 16940565 |
MESH:D008679 |
Metaplasia |
|
Ozone |
5.02 | 10496685 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
3.28 | 18172295 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.42 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
7.31 | 19010910 18608210 19157545 16882708 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
7.31 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.11 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.88 | 16411023 |
MESH:D009369 |
Neoplasms |
|
decitabine |
11.51 | 19116145 19470736 17925555 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
11.51 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
11.51 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
11.51 | 16946489 16594593 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.58 | 20056578 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
3.69 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
7.12 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
7.12 | 9142499 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.80 | 18514411 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
4.36 | 20132043 21332399 11836018 17217161 20518802 16723640 18457598 19632207 18674790 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.36 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
4.02 | 14694615 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
7.77 | 19331143 19259094 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
7.77 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
7.77 | 16936753 |
MESH:D010146 |
Pain |
|
Acetaminophen |
6.34 | 16870215 |
MESH:D010146 |
Pain |
|
Tretinoin |
6.34 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
5.27 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
5.27 | 15976015 |
MESH:D010538 |
Peritonitis |
|
Ozone |
4.04 | 16369182 |
MESH:D011014 |
Pneumonia |
|
Butylated Hydroxytoluene |
11.04 | 11893704 |
MESH:D011014 |
Pneumonia |
|
Ozone |
11.04 | 18381685 18929643 18007984 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
marker/mechanism |
|
| 17344919 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.64 | 17616702 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.33 | 16039940 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.52 | 16636307 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.71 | 16723453 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.34 | 19058328 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
10.67 | 19155313 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
10.67 | 16283617 16116481 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
5.66 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
5.66 | 16467112 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.73 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.52 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.52 | 17261132 |
MESH:D013964 |
Thyroid Neoplasms |
|
4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine |
11.86 | 16940797 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
11.86 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
11.86 | 17045167 16026305 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.71 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.17 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
5.14 | 19087683 17616700 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
5.14 | 11723127 17306315 16452187 16712894 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.89 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
9.15 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
9.15 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
12.56 | 17785578 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
12.56 | 16752155 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.34 | 17056641 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.97 | 16761959 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.66 | 16723640 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.89 | 16287080 |